D.E. Shaw & Co’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-126,497
| Closed | -$244K | – | 3396 |
|
2024
Q3 | $244K | Buy |
+126,497
| New | +$244K | ﹤0.01% | 2756 |
|
2024
Q1 | – | Sell |
-95,567
| Closed | -$310K | – | 3409 |
|
2023
Q4 | $310K | Sell |
95,567
-29,073
| -23% | -$94.2K | ﹤0.01% | 2560 |
|
2023
Q3 | $318K | Buy |
124,640
+37,328
| +43% | +$95.2K | ﹤0.01% | 2453 |
|
2023
Q2 | $513K | Buy |
87,312
+75,478
| +638% | +$443K | ﹤0.01% | 2338 |
|
2023
Q1 | $33.7K | Sell |
11,834
-26,002
| -69% | -$74.1K | ﹤0.01% | 2978 |
|
2022
Q4 | $76.1K | Buy |
37,836
+9,552
| +34% | +$19.2K | ﹤0.01% | 3164 |
|
2022
Q3 | $82K | Buy |
28,284
+2,844
| +11% | +$8.25K | ﹤0.01% | 3351 |
|
2022
Q2 | $143K | Sell |
25,440
-13,076
| -34% | -$73.5K | ﹤0.01% | 3493 |
|
2022
Q1 | $454K | Buy |
+38,516
| New | +$454K | ﹤0.01% | 3258 |
|